Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel

International Journal of Cardiology

Volumn 177, Issue 3, 2014, Pages 1073-1075

  Siasos, Gerasimos ^a   Kioufis, Stamatios ^a   Oikonomou, Evangelos ^a   Zaromitidou, Marina ^a   Vavuranakis, Manolis ^a   Maniatis, Konstantinos ^a   Papageorgiou, Nikolaos ^a   Mourouzis, Konstantinos ^a   Papaioannou, Spyridon ^a   Tsalamandris, Sotiris ^a   Papavassiliou, Athanasios G ^a   Stefanadis, Christodoulos ^a   Tousoulis, Dimitris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Arterial stiffness; C34T polymorphism; Clopidogrel; Coronary artery disease; Flow mediated dilation

Indexed keywords

CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR; P2RY12 PROTEIN, HUMAN; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

ADULT; ARTERIAL STIFFNESS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOTE DETECTION; HUMAN; LETTER; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; P2Y12 GENE; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; AGED; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETICS; GENOTYPE; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

AGED; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; TICLOPIDINE; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84919954501     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.10.060     Document Type: Article

References (13)

1. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N. Engl. J. Med. 345 2001 494 502
2. D. Tousoulis, G. Siasos, and M. Zaromytidou The role of the cytochrome P450 polymorphisms in clopidogrel efficacy and clinical utility Curr. Med. Chem. 18 2011 427 438
3. C. Antoniades, D. Tousoulis, and C. Vasiliadou Genetic polymorphism on eNOS gene modifies the smoking-associated risk for myocardial infarction in young individuals: a gene-environment interaction Eur. Heart J. 28 2007 585 586
4. C. Antoniades, D. Tousoulis, and C. Vasiliadou Genetic polymorphism C807T but not A1648G on platelet glycoprotein Ia, increases the risk of premature myocardial infarction by modifying platelet activation in the presence of endothelial dysfunction Eur. Heart J. 28 2007 566-566
5. M.C. Corretti, T.J. Anderson, and E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J. Am. Coll. Cardiol. 39 2002 257 265
6. M.W. Rajzer, W. Wojciechowska, M. Klocek, I. Palka, M. Brzozowska-Kiszka, and K. Kawecka-Jaszcz Comparison of aortic pulse wave velocity measured by three techniques: Complior, SphygmoCor and Arteriograph J. Hypertens. 26 2008 2001 2007
7. R. Kelly, C. Hayward, A. Avolio, and M. O'Rourke Noninvasive determination of age-related changes in the human arterial pulse Circulation 80 1989 1652 1659
8. E. Karpanou, G. Vyssoulis, and K. Keramida Smoking is related to inflammatory burden in patients with essential hypertension Eur. Heart J. 28 2007 586-586
9. S. Laurent, J. Cockcroft, and L. Van Bortel Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur. Heart J. 27 2006 2588 2605
10. G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, and G. Di Sciascio High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study J. Am. Coll. Cardiol. 57 2011 771 778
11. C. Meune, I. Mahe, and A.C. Solal Comparative effect of aspirin and clopidogrel on arterial function in CHF Int. J. Cardiol. 106 2006 61 66
12. A. Warnholtz, M.A. Ostad, and N. Velich A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study Atherosclerosis 196 2008 689 695
13. T. Heitzer, V. Rudolph, and E. Schwedhelm Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects Arterioscler. Thromb. Vasc. Biol. 26 2006 1648 1652